DWA
CALA

Dorsey Wright & Associates’s Calithera Biosciences, Inc CALA Stock Holding History

Dorsey Wright & Associates’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-76
Closed -$7K – 380
2020
Q1 		$7K Buy
+76
New +$9.05K ﹤0.01% 231

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dorsey Wright & Associates's CALA Position: Q2 2020 in Review

Dorsey Wright & Associates sold out of Calithera Biosciences, Inc (CALA) in Q2 2020, closing a stake of 76 shares — an estimated $7K sold.

Dorsey Wright & Associates first reported a position in CALA in Q1 2020 and held it in 1 quarter. The position peaked at $7K in Q1 2020. 110 funds tracked by Wall St. Rank hold CALA as of Q2 2020.

  • Dorsey Wright & Associates reported no remaining Calithera Biosciences, Inc position as of Q2 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 76 Calithera Biosciences, Inc shares in Q2 2020, an estimated $7K.
  • Dorsey Wright & Associates first reported a position in Calithera Biosciences, Inc in Q1 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Calithera Biosciences, Inc position peaked at $7K in Q1 2020.
  • 110 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2020.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.